Skip to main content
. 2014 Jun 4;85(12):1386–1395. doi: 10.1136/jnnp-2014-307712

Table 5.

Comparison of deep grey matter (DGM) inflammation, neurodegeneration and iron density in relation to the cortex and white matter

MS NADGM MS normal-appearing cortex MS normal-appearing white matter
CD3-positive T cells Median 1.7 1.7 2.2
Min.−Max. 0–6.6 0–5.2 0–12.2
CD68-reactive macrophages and microglia/mm2 Median 150.8 145.8 264.8*
Min.−Max. 63.1–310.8 66–217 85.1–505.2
IBA-1-reactive macrophages and microglia /mm Median 222.4 267.4 390.6*
Min.−Max. 35.6–697.9 45.1–817.7 111.1–796.9
iNOS-reactive macrophages and microglia/mm2 Median 76.7 17.4* 9.6*
Min.−Max. 32.1–174.8 0–158 0–107.6
p22-Reactive macrophages and microglia/mm2 Median 347.4 383.7 418.8
Min.−Max. 122.4–704.3 125–788.2 177.1–793.4
% Of p22-positive area Median 1.2 1.4 1.7
Min.−Max. 0–7.3 0.1–7.7 0.2–7
APP-reactive neuronal cell bodies/mm2 Median 0.3 0
Min.−Max. 0–3.5 0–2.5
APP-reactive axonal spheroids/ mm2 Median 3 0 0*
Min.−Max. 0–55.6 0–8.7 0–34.7
% E06-reactive neurons Median 69.1 33.9*
Min.−Max. 19.8–99.0 2.5–86.7
E06-reactive axonal spheroids/mm2 Median 1.5 0* 0*
Min.−Max. 0–224 0–7.4 0–2.6
E06-reactive thin cellular processes/mm2 Median 5.4 0* 0*
Min.–Max. 0–150.5 0–12.2 0–194.4
E06-reactive oligodendrocytes/mm2 Median 15.2 0* 0*
Min.−Max. 0–72.1 0–34.7 0–128.5
E06-reactive lipofuscin/mm2 Median 29.2 17.4* 3.5*
Min.−Max. 1.7–88.5 0–34.7 0–29.5
% E06-positive area Median 3.5 0.1* 0.6*
Min.−Max. 0.1–29.7 0–4.6 0–29
Oxidised DNA-reactive nuclei/mm2 Median 3.5 0* 0*
Min.−Max. 0–19.7 0–15.6 0–12.2
Iron density Median 654.5 306.3* 330.3*
Min.−Max. 391.6–1031.2 238.9–377.7 222.3–733.9

This table depicts a comparison among the extent of inflammatory infiltrates, neurodegeneration and iron density in the normal-appearing deep grey matter (NADGM) (n=30) and the normal-appearing cortex (n=11) and white matter (n=24) of patients with MS. The values represent the median values and range.

*Significant p values after correction for multiple testing in comparison with NADGM.

Microglia and macrophage counts are pooled in order to facilitate the description. In patients with MS, normal-appearing white matter in the internal capsule expressed significantly more CD68 (p<0.001) and IBA-1 (p=0.027) compared with those in the NADGM. All evaluated E06-reactive structures, such as neurons (p<0.001), axonal spheroids (p=0.015 and p=0.002, respectively), thin cellular processes (p=0.014 and p=0.008, respectively), oligodendrocytes (p<0.001 and p<0.001, respectively) and lipofuscin (p=0.021 and p<0.001, respectively), were expressed at significantly higher levels in NADGM than in normal-appearing white matter or cortex. Similarly, the levels of oxidised DNA-reactive nuclei (p=0.039 and p<0.001, respectively) and the percentage of area data (p<0.001 and p=0.004, respectively) were greater in the NADGM than in normal-appearing white matter or cortex. APP-positive axonal spheroids were more often found in the NADGM than in the normal-appearing white matter (p=0.006). The iron content of NADGM was also significantly higher than that in cortical grey matter and normal-appearing white matter (p<0.001 and p<0.001, respectively).

APP, amyloid precursor protein; IBA-1, ionised calcium-binding adapter molecule 1; iNOS, inducible nitric oxide synthase; MS, multiple sclerosis.